F. Zengerling

Final Results from SAUL, a Single-arm International Study of Atezolizumab in Unselected Patients with Pretreated Locally Advanced/Metastatic Urinary Tract Carcinoma.

Y. Loriot, Pari Skamnioti, G. Banna, 2024, European urology focus.

First-line immune combination therapies for non-clear cell vs. clear cell metastatic renal cell carcinoma: Real-world multicenter data from Germany

C. Kalogirou, S. Banek, B. Hoeh, 2024, Clinical Genitourinary Cancer.